# Sensorion: Observational study terminated, 134 enrolled (Sensorineural Hearing Loss, Bilateral)

**Score:** 80/100

| Field | Value |
|---|---|
| Sponsor | Sensorion |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis |
| NCT ID | NCT06354010 |
| Phase | Observational |
| Status | terminated |
| Conditions | Sensorineural Hearing Loss, Bilateral |
| Intervention types | genetic, other |
| Target enrollment | 134 |
| Site countries | United States, France |
| Posted | 2024-04-09 |
| Planned start | 2024-06-14 |
| Event | Terminated |
| Event date | 2026-08-13 |
| Last update posted | 2026-10-26 |

## Why this score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- Stopped early: budget and sites freed up.
- 134 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT06354010). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.